Company intelligence / Profile preview

RiboCor

Minneapolis, Minnesota, United Statesdnb.com ↗

Ownership: Private
Development stage: Other

Overview

RiboCor was a provider of ribose-based technologies aimed at improving cardiovascular function, muscle energy recovery, and tissue function. Its products were marketed to the nutritional supplement, food, and pharmaceutical industries. The company is now defunct.

Therapeutic areas: CardiovascularMetabolic Disorders
Modalities: Small molecule
Industry: Food & Nutrition

Beyond the preview

Go deeper on RiboCor.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RiboCor.

Explore the full profile